Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) Shares Shorted: Short Interest Down 50.2% in October

by · The Cerbat Gem

Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ – Get Free Report) saw a large drop in short interest in the month of October. As of October 15th, there was short interest totaling 82,052 shares, a drop of 50.2% from the September 30th total of 164,782 shares. Approximately 1.3% of the company’s stock are short sold. Based on an average daily trading volume, of 94,563 shares, the short-interest ratio is currently 0.9 days.

Creative Medical Technology Trading Down 3.4%

NASDAQ CELZ traded down $0.02 during trading hours on Friday, reaching $0.66. 87,006 shares of the company’s stock were exchanged, compared to its average volume of 100,397. Creative Medical Technology has a one year low of $0.62 and a one year high of $4.72. The stock has a market cap of $4.32 million, a PE ratio of -0.32 and a beta of 2.06. The firm has a fifty day moving average of $0.93 and a 200-day moving average of $1.57.

Creative Medical Technology (NASDAQ:CELZ – Get Free Report) last issued its quarterly earnings data on Friday, August 7th. The company reported ($0.41) EPS for the quarter, missing analysts’ consensus estimates of ($0.39) by ($0.02). As a group, research analysts forecast that Creative Medical Technology will post -1.18 EPS for the current year.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on CELZ shares. Weiss Ratings downgraded Creative Medical Technology from a “sell (d-)” rating to a “sell (e+)” rating in a report on Thursday, September 24th. Wall Street Zen raised Creative Medical Technology from a “sell” rating to a “hold” rating in a research report on Saturday, September 12th. Finally, Roth Capital restated a “buy” rating on shares of Creative Medical Technology in a research note on Thursday, August 20th. One analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, Creative Medical Technology presently has a consensus rating of “Hold”.

View Our Latest Analysis on Creative Medical Technology

Creative Medical Technology Company Profile

(Get Free Report)

Creative Medical Technology Holdings, Inc is a biotechnology company focused on developing regenerative medicine and cellular therapies. Its research programs are designed to use stem cells and other biological approaches to address conditions for which existing treatment options may be limited.

The company has developed and investigated therapies based on autologous stem cells, meaning cells collected from and administered back to the same patient. Its programs have included CaverStem, a regenerative treatment candidate for erectile dysfunction, as well as investigational platforms such as FemCelz for female sexual dysfunction and ImmCelz, an immune-modulating cellular therapy platform.

Recommended Stories